2,5-Dimethylfuran-3-thiol
Common Name: |
2,5-Dimethylfuran-3-thiol |
IUPAC Name: |
2,5-dimethylfuran-3-thiol |
Molecular Formula: |
C6H8OS |
SMILES: |
CC1=CC(=C(O1)C)S |
Inchi: |
1S/C6H8OS/c1-4-3-6(8)5(2)7-4/h3,8H,1-2H3 |
Inchi Key: |
DBBHCZMXKBCICL-UHFFFAOYSA-N |
Cas No: |
55764-23-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
128.19 |
Mass (g/mol) |
128.03 |
Molar Refractivity |
35.89 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
0 |
Rings |
1 |
TPSA |
51.94 |
Hetero Atoms |
2 |
Heavy Atoms |
8 |
Aromatic Heavy Atoms |
5 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
175.00 to 177.00 |
Vapor Pressure (mmHg@25.00 °C) |
1.907 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.33 |
LogP |
2.185 |
iLOGP |
2.06 |
XLOGP3 |
1.94 |
WLOGP |
2.19 |
MLOGP |
1.11 |
ESOL Log S |
-2.32 |
ESOL Solubility (mg/ml) |
0.614 |
ESOL Solubility (mol/l) |
0.005 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.66 |
Ali Solubility (mg/ml) |
0.28 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.46 |
Silicos-IT Solubility (mg/ml) |
0.45 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.70 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.811 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.453 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Danger |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |